ericjones12398 writes: "International pharmaceutical giant Novartis is suing the United Kingdom's national health system (NHS) for using a cheaper, unlicensed drug instead of Novartis' licensed drug for treating age-related blindness. Even if Novartis wins the legal battle in the UK, and forces the NHS to use the $1,000 drug, it will (and already has) generated numerous counts of negative publicity for the company. During a time when health care costs are soaring, a low-cost alternative medication will always be favored by the public and physicians, no matter what health care regulations apply."
DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Also, Slashdot's Facebook page has a chat bot now. Message it for stories and more. Check out the new SourceForge HTML5 internet speed test! ×